Results 71 to 80 of about 349,588 (308)

Medical student education in transfusion medicine: Proposal from the "European and Mediterranean initiative in transfusion medicine".

, 2018
A large body of observations indicate that there is an inconsistent knowledge of Transfusion Medicine among health care professionals as well as inconsistent knowledge in all aspects of the transfusion process, from blood donation to transfusion on the ...
Garraud, O., Laspina, S., Politis, C., de Angelis, V., Brand, A., Ertuğrul Örüç, N., Henschler, R., Haddad, A., Lozano, M., Vuk, T., Tissot, J.D.   +10 more
core   +1 more source

Prediction of Long‐Term Prognosis in Patients With Hepatocellular Carcinoma Using the National Clinical Database Risk Calculator

Annals of Gastroenterological Surgery, EarlyView.
This study aimed to determine the value of the National Clinical Database (NCD) risk calculator in predicting surgical outcomes and long‐term prognosis in patients undergoing resection for hepatocellular carcinoma (HCC). We retrospectively analyzed data from 210 patients with HCC who underwent initial hepatic resection, assessing the relationship ...
Mariko Tsukagoshi, Kenichiro Araki, Norio Kubo, Takamichi Igarashi, Shunsuke Kawai, Kei Hagiwara, Kouki Hoshino, Ryo Muranushi, Ken Shirabe   +8 more
wiley   +1 more source

DRGs in Transfusion Medicine and Hemotherapy in Germany [PDF]

, 2012
Patients requiring transfusion medicine and hemotherapy in an inpatient setting are incorporated into the German Diagnosis Related Groups (G-DRG) system in multiple ways.
Ostermann, Helmut, Bauer, Matthäus
core   +1 more source

Amotosalen/ultraviolet A pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance

Haematologica, 2017
Amotosalen and ultraviolet A (UVA) photochemical-based pathogen reduction using the Intercept™ Blood System (IBS) is an effective and established technology for platelet and plasma components, which is adopted in more than 40 countries worldwide. Several
Simona Stivala, Sara Gobbato, Laura Infanti, Martin F. Reiner, Nicole Bonetti, Sara C. Meyer, Giovanni G. Camici, Thomas F. Lüscher, Andreas Buser, Jürg H. Beer   +9 more
doaj   +1 more source

You may need a blood transfusion

, 2021
This leaflet is designed to help you and your family understand what a blood transfusion is and how you can help make this a safer treatment for you. Your doctor or nurse will explain if you are likely to need a blood transfusion and why. They will
National Transfusion Advisory Group (NATG)
core  

Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial [PDF]

, 2003
A nucleic acid-targeted photochemical treatment (PCT) using amotosalen HCl (S-59) and ultraviolet A (UVA) light was developed to inactivate viruses, bacteria, protozoa, and leukocytes in platelet components.
Ljungman, P. (Per), Metzel, P. (Peyton), Kappers-Klunne, M.C. (Mies), Rhenen, D.J. (Dirk Jan) van, Marblie, S. (Stephane), Mayaudon, V. (Veronique), Lin, L. (Lily), Cazenave, J.P., Pamphilon, D. (Derwood), Laforet, M. (Michel), Lioure, B. (Bruno), Greef, G.E. (Georgine) de, Gulliksson, H. (Hans), Kluter, H., Buchholz, D. (Don), Flament, J. (Jocelyne), Vermeij, H. (Hans), Conlan, M. (Maureen), Davis, K. (Kathryn), Corash, L. (Laurence), van, Rhenen D, D. van Rhenen, Gulliksson, Hans, Cazenave, Jean-Pierre, Klüter, H, Klüter, Harald, Cazenave, J-P, Marblie, S, Corash, L, Buchholz, Don, Lin, Lily, Ljungman, Per, Laforet, M, Gulliksson, H, Flament, Jocelyne, Ljungman, P,, Metzel, Peyton, Laforet, Michel, Vermeij, Hans, Conlan, Maureen, de, Greef G, Pamphilon, DH, Kappers-Klunne, Mies, Pamphilon, D, Klunne, Mies, Pamphilon, Derwood, Rhenen, Dick, Lioure, B, Mayaudon, V, Lioure, Bruno, Corash, Laurence, Conlan, M, Buchholz, D, Vermeij, H, Ljungman, P, Davis, Kathryn, Greef, Georgine, Gulliksson, H,, Lin, L, Davis, K, de Greef, Georgine, Kappers-Klunne, M, Flament, J, Metzel, P, Mayaudon, Véronique, Marblie, Stephane, van Rhenen, Dick   +66 more
core   +2 more sources

Preoperative FIB‐4 Index as a Potential Factor Associated With Severe Postoperative Complications and Endogenous Organ Failure After Hepatectomy for Hepatocellular Carcinoma

Annals of Gastroenterological Surgery, EarlyView.
This study demonstrates that a preoperative FIB‐4 index ≥ 5.0 independently predicts severe complications and endogenous organ failure (EOF) following hepatectomy for hepatocellular carcinoma. By capturing structural liver fragility and systemic vulnerability, the FIB‐4 index enhances surgical risk stratification beyond traditional functional markers ...
Masanori Nakamura, Yukiyasu Okamura, Osamu Aramaki, Nao Yoshida, Yusuke Mitsuka, Hayato Abe, Shunsuke Yamagishi, Yasuhiro Okumura, Kyongsun Pak, Shinobu Masuda   +9 more
wiley   +1 more source

Platelet antibody screening and analysis of influencing factors [PDF]

Xin yixue
Objective To analyze the positive rate distribution of platelet antibodies in different types of patients and different diseases by screening platelet antibodies in 27， 239 emergent and hospitalized patients， aiming to explore the influencing factors of ...
LAI Peibin, XU Lijuan, CEN Zhihua, ZHAO Caihan, LU Ying, ZOU Yong
doaj   +1 more source

Targeting B‐Cell‐Activating Factor and Its Receptor in Immune Thrombocytopenia and Warm Autoimmune Hemolytic Anemia

American Journal of Hematology, EarlyView.
ABSTRACT Current treatments for immune thrombocytopenia (ITP) and warm autoimmune hemolytic anemia (wAIHA), rare autoimmune diseases in which autoreactive B cells play a major role, can lead to high response rates; however, for many patients these responses are not durable or maintained after treatment discontinuation.
Matthieu Mahévas, Nichola Cooper, Vickie McDonald, Karina Yazdanbakhsh, Wilma Barcellini   +4 more
wiley   +1 more source

Phase II Study of Posttransplant Cyclophosphamide‐Based Graft‐Versus‐Host Disease Prophylaxis After HLA‐Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort

American Journal of Hematology, EarlyView.
ABSTRACT Posttransplant cyclophosphamide (PTCy) to prevent graft‐versus‐host disease (GVHD) improves outcomes in recipients of HLA mismatched unrelated donor (MMUD) allogeneic hematopoietic cell transplantation (allo HCT). Outcomes of MMUD HCT using PTCy in patients requiring reduced intensity or non‐myeloablative conditioning (RIC/NMA) are not well ...
Brian C. Shaffer, Monzr M. Al Malki, Antonio Martin Jimenez Jimenez, Joseph Stanek, Stephanie Bo‐Subait, Brent R. Logan, Jianqun Kou, Erin Leckrone, Heather E. Stefanski, Stephen R. Spellman, Craig Malmberg, Medhat Askar, Rachel Cusatis, Dipenkumar Modi, Farhad Khimani, Mehdi Hamadani, Martin Maiers, Rachel Cook, Karen Ballen, Javier Bolaños‐Meade, Uttam Rao, Jordan Milner, Ramzi Abboud, Katarzyna Jamieson, George Carrum, Bhagirathbhai Dholaria, William J. Hogan, Ran Reshef, Satyajit Kosuri, Alison Loren, Karilyn Larkin, Sally Arai, Muna Qayed, Sung Won Choi, Larisa Broglie, Jeffery J. Auletta, Bronwen E. Shaw, Steven M. Devine, Mahasweta Gooptu   +38 more
wiley   +1 more source